Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_assertion type Assertion NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_head.
- NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_assertion description "[We hypothesized that inhibiting MPI enzymatic activity would provide more Man-6-P for glycosylation and possibly benefit CDG-Ia patients with residual PMM2 activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_provenance.
- NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_assertion evidence source_evidence_literature NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_provenance.
- NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_assertion SIO_000772 21949237 NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_provenance.
- NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_assertion wasDerivedFrom befree-20140225 NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_provenance.
- NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_assertion wasGeneratedBy ECO_0000203 NP211953.RA_PylPAO1LH4V5xoMLBOaEdjn69XPGoeU9ady6imUG0s130_provenance.